Viatris Inc.'s Q1 2025 earnings show declining revenues and profits, yet the stock rose nearly 10% due to stable full-year guidance and positive pipeline updates. The company's significant debt reduction from $22.4bn to $14.3bn came at the cost of selling key assets, raising concerns about long-term growth. Viatris faces challenges like tariffs, FDA warnings, and geopolitical uncertainties, impacting its operational stability and future profitability....
Seeking Alpha - 5/8/2025 12:41:09 PM
More News for VTRS
Stock Analysis for VTRS
Related Stocks: